Harvard Bioscience Inc. (HBIO) PT Raised to $7 at Benchmark, 'Q1 Beat & Raise; Outlook Improving; Raising Price Target'
Go back to Harvard Bioscience Inc. (HBIO) PT Raised to $7 at Benchmark, 'Q1 Beat & Raise; Outlook Improving; Raising Price Target'| Harvard Bioscience, Inc. (NASDAQ: HBIO) | Delayed: 6.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.13 | 52 Week High | $3.90 | |||
| Open | $6.13 | 52 Week Low | $2.25 | |||
| Day High | $6.13 | P/E | N/A | |||
| Day Low | $6.13 | EPS | $-0.03 | |||
| Volume | 31 | |||||
